Indian pharma CDMOs remain resilient, continuing to thrive due to favorable global factors. The B&K Securities report ...
Asian News International on MSN13d
US tariffs will have minimal impact on Indian pharma service companies like CDMOs: ReportIndian pharma companies like CDMOs (Contract Development and Manufacturing Organizations) will not see major disruptions from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback